Anti-interleukin-6 Myopathy Agalsidase Analyses multidimensionnelles Active Adeno-associated vector Antibodies Abnormal movement Muscle AAV antibody Anti-IgE IgG IMNM Polymyositis Middle Aged Machine learning Dependovirus/genetics/immunology Aged Auto-antibodies Anti-drug antibodies Adverse drug reactions Adult Auto‐antibodies AAV Anti‐mitochondrial antibodies Male Cancer Multidisciplinarity AAV vectors Mass cytometry Anti-MDA5 autoantibodies AAV vector Inclusion body myositis DM Myositis and muscle disease Amyotrophy Anémie hémolytique Assisted communication devices Autoimmune diseases Immune checkpoint inhibitors Sphingosine-1-phosphate Gene therapy Fabry disease B-lymphocyte Amyotrophic lateral sclerosis Adeno-associated virus vector Myocarditis Aldostérone IBM CD8+T cells Anticorps anti-agalsidase Prognosis Inborn errors of metabolism Female CD8+ T-bet+ cells Biopsy Anti-synthetase syndrome Bioelectrical impedance analysis Outcome measures Systems biology Skeletal muscle Myositis Biomarqueurs Antisynthétase Arthritis Antiphospholipid syndrome Autoimmunity Acid-alpha-glucosidase Humans AAV humoral immunity Case reports Lysosomal storage diseases Acute Kidney Injury/epidemiology/etiology Adjudication Adeno-associated virus Immunotherapy Biomarker Inflammatory myopathy Interstitial lung disease Deep immune profiling Antisynthetase syndrome Anticorps spécifique des myosites Aldosterone Autoantibodies Interferon Data integration Auto-immunité Animals Cytokines Adolescence Idiopathic inflammatory myopathies Inflammation COVID-19 Anti-agalsidase antibodies Dermatomyositis Autoantibody B cell homeostasis Anti-Mi2 Antibody responses Biomarkers Antisynthetase